📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cellcentric

1.1 - Company Overview

Cellcentric Logo

Cellcentric

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biotechnology therapies targeting p300/CBP inhibition to treat specific cancers, particularly solid tumors; developing the oral drug Inobrodib, currently in Phase I/II trials, with potential utility in non-small cell lung, breast, colon cancers and multiple myeloma.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cellcentric

BioNovion Logo

BioNovion

HQ: United States Website
  • Description: Provider of immune oncology antibody discovery and development focused on antibodies for the immune therapy of cancer; U.S.-based, founded in 2011 and acquired by Aduro BioTech in 2015.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioNovion company profile →
Delcath Systems Logo

Delcath Systems

HQ: United States Website
  • Description: Provider of interventional oncology therapies for metastatic liver cancer, including HEPZATO KIT for adult patients with metastatic uveal melanoma using a hepatic delivery system; the CHEMOSAT Hepatic Delivery System for melphalan for percutaneous hepatic perfusion to treat liver cancers; and Percutaneous Hepatic Perfusion, a minimally invasive procedure delivering high-dose chemotherapy directly to the liver while isolating the organ from the body’s circulatory system.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Delcath Systems company profile →
Xcell Biosciences Logo

Xcell Biosciences

HQ: United States Website
  • Description: Provider of a next-generation development and manufacturing platform for enhanced cell therapy performance, offering AVATAR Foundry, an automated closed system for autologous cell therapy production (in beta); AVATAR System, an incubator that fine-tunes oxygen and pressure to mimic in vivo; AVATAR AI, software using machine learning for drug behavior prediction and potency assay development; and AVATAR AD, a four-instrument system for assay development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Xcell Biosciences company profile →
Imvaq Therapeutics Logo

Imvaq Therapeutics

HQ: United States Website
  • Description: Provider of innovative cancer immunotherapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Imvaq Therapeutics company profile →
Eikonoklastes Logo

Eikonoklastes

HQ: United States Website
  • Description: Provider of gene therapies that increase Caveolin-1 expression in neurons to address neurodegenerative diseases, including ET-101, designed to overexpress Caveolin-1 and potentially benefit patients with ALS, Parkinson’s, Huntington’s, MS, and dementia, and SynCav1, which enhances neuroprotection and neuroplasticity for a wide range of neurodegenerative conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eikonoklastes company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cellcentric

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cellcentric

2.2 - Growth funds investing in similar companies to Cellcentric

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cellcentric

4.2 - Public trading comparable groups for Cellcentric

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cellcentric

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cellcentric

What does Cellcentric do?

Cellcentric is a provider of clinical-stage biotechnology therapies targeting p300/CBP inhibition to treat specific cancers, particularly solid tumors; developing the oral drug Inobrodib, currently in Phase I/II trials, with potential utility in non-small cell lung, breast, colon cancers and multiple myeloma.

Who are Cellcentric's competitors?

Cellcentric's competitors and similar companies include BioNovion, Delcath Systems, Xcell Biosciences, Imvaq Therapeutics, and Eikonoklastes.

Where is Cellcentric headquartered?

Cellcentric is headquartered in United Kingdom.

How many employees does Cellcentric have?

Cellcentric has 1,000 employees 🔒.

When was Cellcentric founded?

Cellcentric was founded in 2010 🔒.

What sector and industry vertical is Cellcentric in?

Cellcentric is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cellcentric

Who are the top strategic acquirers in Cellcentric's sector and industry

Top strategic M&A buyers and acquirers in Cellcentric's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cellcentric?

Top strategic M&A buyers groups and sectors for Cellcentric include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cellcentric's sector and industry vertical

Which are the top PE firms investing in Cellcentric's sector and industry vertical?

Top PE firms investing in Cellcentric's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cellcentric's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cellcentric's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cellcentric's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cellcentric include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cellcentric's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cellcentric?

The key public trading comparables and valuation benchmarks for Cellcentric include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cellcentric for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cellcentric with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cellcentric's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cellcentric with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cellcentric's' sector and industry vertical?

Access recent funding rounds and capital raises in Cellcentric's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cellcentric